Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Noninvasive Atrophic Acne Scar Treatment in Asians With a 755-nm Picosecond Laser Using A Diffractive Optic Lens—A Retrospective Photographic Review

Huang, Ching-Hsin, MD*; Chern, Erick, MD*; Peng, Jui-Hui; Hsien-Li Peng, Peter, MD*

doi: 10.1097/DSS.0000000000001669
Original Article
Buy

BACKGROUND The diffractive lens of the picosecond laser is relatively new, and there are few reports on its efficacy in treating atrophic acne scars, especially in Asian populations.

OBJECTIVE Evaluating the efficacy of diffractive lens 755-nm picosecond laser for atrophic acne scar treatment in Asians.

PATIENTS AND METHODS Forty-two patients who were treated for facial atrophic acne scars at a private dermatological clinic were enrolled in this retrospective analysis. Mean session count was 4.28. Before and after photographs were assessed by 2 blinded dermatologists, who rated the amount of overall skin quality improvement on a 5-point scale.

RESULTS All patients experienced improvements in scar texture and overall skin quality after 2 to 6 sessions, with scores of +1.4, 1.45, 1.7, 1.33, 2.3, and 1.66 points after 2, 3, 4, 5, 6, and >6 treatments, respectively. There were no obvious adverse effects after treatment. The postinflammatory hyperpigmentation (PIH) risk was 4.7% (2 of 42, both spontaneously resolved).

CONCLUSION The 755-nm diffractive lens picosecond laser showed good efficacy and low PIH rates when treating atrophic acne scars in darker skin–type patients. In addition to treatment results, additional improvements in overall skin quality and pigmentation make the picosecond laser an effective and desirable treatment option for Asians.

*P-Skin Professional Clinic, Kaohsiung, Taiwan, China;

National Yang-Ming University School of Medicine, Taipei, Taiwan, China

Address correspondence and reprint requests to: Peter Hsien-Li Peng, MD, P-Skin Professional Clinic, 103 Tsoying Great Road, Tsoying District, Kaohsiung, 81347, Taiwan, China, or e-mail: pengskin@gmail.com

The authors have indicated no significant interest with commercial supporters.

© 2019 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website